Secondary structure changes of ox-LDL by photoirradiation in an optofluidic resonator

Yuxi Shang; Hailang Dai; Daopeng Dai; Jinmao Gu; Meng Zhang; Qiheng Wei; Xianfeng Chen

doi:10.3788/COL202220.031702

[1] J. Sanz, Z. Fayad. Imaging of atherosclerotic cardiovascular disease. Nature, 451, 953(2008).

[2] J. L. Aldons. Atherosclerosis. Nature, 407, 233(2000).

[3] P. Libby, P. Ridker, G. Hansson. Progress and challenges in translating the biology of atherosclerosis. Nature, 473, 317(2011).

[4] S. Tatsuya, K. Noriaki, A. Takuma, M. Hideaki, H. Hajime, A. Yuichi, T. Takeshi, M. Soichi, K. Yoshimoto, K. Toru, M. Tomoh. An endothelial receptor for oxidized low-density lipoprotein. Nature, 386, 73(1997).

[5] S. Parthasarathy, A. Raghavamenon, M. O. Garelnabi, N. Santanam. Oxidized low-density lipoprotein. Methods Mol. Biol., 610, 403(2010).

[6] M. Tamminen, G. Mottino, J. Qiao, J. Breslow, J. Frank. Ultrastructure of early lipid accumulation in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol., 19, 847(1999).

[7] K. Nakajima, T. Nakano, A. Tanaka. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clinica Chimica Acta, 367, 36(2006).

[8] M. Quinn, S. Parthasarathy, L. Fong, D. Steinberg. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. U. S. A., 84, 2995(1987).

[9] S. Mitra, A. Deshmukh, R. Sachdeva, J. Lu, J. L. Mehta. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am. J. Med. Sci., 342, 135(2011).

[10] T. Andreja, I. Resanovic, S. Julijana, R. Djordje, A. M. Shaker, C. M. Desanka, J. Danimir, R. I. Esma. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases. Crit. Rev. Clin. Lab. Sci., 52, 70(2015).

[11] S. Choi, R. Harkewicz, J. H. Lee, A. Boullier, F. Almazan, A. C. Li, J. L. Witztum, Y. S. Bae, I. M. Yury. Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ. Res., 104, 1355(2009).

[12] R. Carnevale, S. Bartimoccia, C. Nocella, D. S. Serena, L. Lorenzo, I. Giulio, L. Elisabetta, B. Valentina, D. B. Maria, D. M. Luigi, P. Pasquale, V. Francesco. LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism. Atherosclerosis, 237, 108(2014).

[13] G. Obermayer, T. Afonyushkin, C. J. Binder. Oxidized low-density lipoprotein in inflammation-driven thrombosis. J. Thromb. Haemost., 16, 418(2018).

[14] S. A. Thorne, S. E. Abbot, P. G. Winyard, D. R. Blake, P. G. Mills. Extent of oxidative modification of low density lipoprotein determines the degree of cytotoxicity to human coronary artery cells. Heart, 75, 11(1996).

[15] H. Kataoka, N. Kume, S. Miyamoto, M. Minami, M. Morimoto, K. Hayashida, N. Hashimoto, T. Kita. Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 21, 955(2001).

[16] F. Sigala, K. Athanassios, S. Paraskevi, F. Konstantinos, M. Sophia, K. I. Efstathios, G. G. Vassilis, A. Ioanna. Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability. J. Vasc. Surg., 52, 704(2010).

[17] S. M. Marcovina, F. Crea, J. Davignon, J. C. Kaski, W. Koenig, U. Landmesser, P. L. Pieri, M. J. Schulz, L. J. Shaw, J. Sobesky. Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools. J. Intern. Med., 261, 214(2007).

[18] H. Itabe, M. Ueda. Measurement of plasma oxidized low-density lipoprotein and its clinical implications. J. Atheroscler. Thromb., 14, 1(2007).

[19] A. Sato, Y. Yamazaki, K. Ebina. A method for in vitro measurement of oxidized low-density lipoprotein in blood, using its antibody, fluorescence-labeled heptapeptide and polyethylene glycol. J. Fluoresc., 27, 1985(2017).

[20] A. Zinellu, S. Salvatore, G. Franca, L. Fiorenza, P. Valeria, M. P. Giovanni, T. Bruna, D. Luca, C. Ciriaco. Applications on the monitoring of oxidative modification of LDL by capillary electrophoresis: a comparison with spectrophotometer assay. Talanta, 64, 428(2004).

[21] J. Stocks, N. Miller. Analysis of apolipoproteins and lipoproteins by capillary electrophoresis. Electrophoresis, 20, 2118(1999).

[22] H. Hinterwirth, G. Stübiger, W. Lindner, M. Lämmerhofer. Gold nanoparticle-conjugated anti-oxidized low-density lipoprotein antibodies for targeted lipidomics of oxidative stress biomarkers. Anal. Chem., 85, 8376(2013).

[23] E. Haller, G. Stübiger, D. Lafitte, W. Lindner, M. Lämmerhofer. Chemical recognition of oxidation-specific epitopes in low-density lipoproteins by a nanoparticle based concept for trapping, enrichment, and liquid chromatography-tandem mass spectrometry analysis of oxidative stress biomarkers. Anal. Chem., 86, 9954(2014).

[24] H. Dai, L. Yuan, C. Yin, Z. Cao, X. Chen. Direct visualizing the spin Hall effect of light via ultrahigh-order modes. Phys. Rev. Lett., 124, 053902(2020).

[25] H. Li, Z. Cao, H. Lu, Q. Shen. Free-space coupling of a light beam into a symmetrical metal-cladding optical waveguide. Appl. Phys. Lett., 83, 2757(2003).

[26] C. Yin, X. Kan, K. Guo, T. Wang, J. Xu, Q. Han, J. Wu, Z. Cao. Highly twisted M-line of a vortex beam due to the coupling of ultrahigh-order modes. Chin. Opt. Lett., 19, 071403(2021).

[27] G. Hansson. Mechanisms of disease-inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med., 352, 1685(2005).

[28] A. Halil, P. Bahar. Effect of purification, dehydration, and coagulation processes on the optical parameters of biological tissues. Chin. Opt. Lett., 19, 011701(2021).

[29] Y. H. Chen, J. T. Yang, K. H. Chau. Determination of the helix and β form of proteins in aqueous solution by circular dichroism. Biochemistry, 13, 3350(1974).